DIFFERENTIAL DIAGNOSIS METHOD FOR DISTINGUISHING THE CASES OF REACTIVE DEPRESSION AND THERAPEUTICALLY RESISTANT REACTIVE DEPRESSION
FIELD: medicine. ^ SUBSTANCE: method involves evaluating patient state using Hamilton scale, considering leukocyte formula of general clinical blood analysis for determining infrared spectroscopy absorption spectrum values within 30 s in the bandwidth of 3085-2832 cm-1 and 1543-1425 cm-1, respective...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine. ^ SUBSTANCE: method involves evaluating patient state using Hamilton scale, considering leukocyte formula of general clinical blood analysis for determining infrared spectroscopy absorption spectrum values within 30 s in the bandwidth of 3085-2832 cm-1 and 1543-1425 cm-1, respectively. Mean value of depression intensity being equal to 21.0±2.8 points, mean absorption values being equal to 32.3±1.8% and 35.0±2.2% in the bandwidth of 3085-2832 cm-1 and 1543-1425 cm-1, respectively and normal lymphocyte and monocyte content being observed, reactive depression is to be diagnosed. Mean absorption values being equal to 40.5±3.2% and 43.4±2.9% in the bandwidth of 3085-2832 cm-1 and 1543-1425 cm-1, respectively in combination with immunity characteristics like monocytosis>5% and lymphocytosis>25% leukocyte formula of general clinical blood analysis being observed, therapeutically resistant reactive depression cases are to be diagnosed. ^ EFFECT: high accuracy of diagnosis in differentiating cases showing positive changes as response to pharmacotherapy from therapeutically resistant cases. ^ 1 tbl |
---|